Hemolytic Uremic Syndrome in the Setting of COVID-19 Successfully Treated with Complement Inhibition Therapy: an Instructive Case Report of a Previously Healthy Toddler and Review of Literature.
Frontiers in Pediatrics(2023)
Key words
hemolytic uremic syndrome,HUS,thrombotic microangiopathy,TMA,COVID-19,complement blockade,ravulizumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined